CAI.US Caris Life Sciences, Inc. Common Stock

Healthcare Life Sciences Tools & Services USA Stocks
23.04 USD
Close of Nov 14, 2026
14.19 36.50
Market cap
USD 6.61B
P/E
13.9x
P/B
10.75x
ROE
2.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CAI.US undervalued?

Graham number
Price23.04
Graham value8.95
Premium157.5%

CAI.US trades 157.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Caris Life Sciences, Inc. Common Stock fundamental analysis

No fundamental analysis for Caris Life Sciences, Inc. Common Stock yet.

Caris Life Sciences, Inc. Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Caris Life Sciences, Inc. Common Stock

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular …

Full company profile